Ibraheem Motabi

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi et al. · Blood · 2012 · 381 citations · Full text

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

Ibraheem Motabi, Armin Ghobadi, Jingxia Liu et al. · Biology of Blood and Marrow Transplantation · 2016 · 54 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Immunotherapy +19

Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

Riad El Fakih, Alfadil Haroon, Feras Alfraih et al. · Bone Marrow Transplantation · 2021 · 21 citations · Full text

Clinical Course, Regional Report, Transplantation +11

Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcomeof 24 patients treated at a Tertiary Care Center in Saudi Arabia

Shahid Iqbal, Syed Ziauddin A. Zaidi, Ibraheem Motabi et al. · Pakistan Journal of Medical Sciences · 2016 · 17 citations · Full text

Cold agglutinin disease after COVID‐19 vaccine

Shaima Al Aoun, Ibraheem Motabi · British Journal of Haematology · 2021 · 13 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +20